Connect with us

Health

Foresight Diagnostics to demonstrate utility of PhasED-Seq technology at ICML meeting – News-Medical.Net

Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance…

Published

on

Article feature image

Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the 16th…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Should face masks be made mandatory for children in schools? – ABC News
Article feature image
Radio-wave therapy is safe for liver cancer patients and shows improvement in overall survival, study suggests – Science Daily